Fluorine chemistry plays an increasingly vital role in modern pharmaceuticals, with an estimated 20-25% of all commercial drugs containing at least one fluorine atom. The unique properties conferred by fluorine—such as increased metabolic stability, enhanced bioavailability, and improved binding affinity—make fluorinated pharmaceutical building blocks indispensable. Efficient global sourcing of these specialized compounds is crucial for pharmaceutical companies worldwide, allowing them to access cutting-edge ingredients and maintain competitive drug development pipelines.


Among these critical fluorinated building blocks is 4-Chloro-2-(trifluoroacetyl)aniline hydrochloride (CAS: 173676-59-0), a key Efavirenz intermediate supplier. This compound is fundamental for the synthesis of Efavirenz, a widely used antiretroviral drug. The trifluoromethyl group within its structure is a prime example of how fluorine incorporation can enhance the biological activity of an API. Sourcing this particular compound requires a reliable 4-chloro-2-(trifluoroacetyl)aniline hydrochloride manufacturer capable of delivering high-purity material consistently.


NINGBO INNO PHARMCHEM CO.,LTD. stands as a prominent supplier in the global market for fluorinated pharmaceutical building blocks. Our commitment to quality ensures that when you choose to purchase 4-chloro-2-trifluoroacetyl-aniline-hydrochloride from us, you receive a product with an assay purity of ≥99.0%. This high standard is essential for seamless integration into complex drug synthesis processes, reducing the need for extensive purification and accelerating time-to-market for new therapies.


The strategic advantage of partnering with a global supplier like NINGBO INNO PHARMCHEM CO.,LTD. extends to competitive pricing and robust supply chain management. We strive to provide a favorable 4-chloro-2-(trifluoroacetyl)aniline hydrochloride price, making essential fluorinated intermediates accessible for pharmaceutical innovation globally. This commitment supports the continuous development of life-saving drugs by ensuring a steady and high-quality supply of these critical chemical components.